In 9 of the 12 tumor cell suspensions tested (BT4 to BT12), most NKG2D+ among the CD45–EpCAMhigh cells had E-cadherin/N-cadherin patterns consistent with either partial (E-cadherin+N-cadherin+) or more progressed (E-cadherin–N-cadherin+) EMT (Figure 4A and 4B). This evidence concerns the gene KLRK1 and neoplasm.